Literature DB >> 749928

The determinants of irreversibly sickled cells in homozygous sickle cell disease.

G R Serjeant, B E Serjeant, P Desai, K P Mason, A Sewell, J M England.   

Abstract

The relationship between the irreversibly sickled cell (ISC) count and other haematological parameters has been investigated. Positive correlations occurred with the MCH, MCHC, and with two expressions of intracellular Hb S content. Since the ISC has a high MCHC, the positive correlations with MCHC and with factors derived from the MCHC may be difficult to evaluate. Negative correlations occurred with total haemoglobin and Hb F. The MCHC was found to affect the relationship between HbF and ISC count, a low MCHC being associated with, and probably determining, lower ISC counts at any level of Hb F. It is proposed that a low MCHC may inhibit ISC formation and the practical implications of this are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 749928     DOI: 10.1111/j.1365-2141.1978.tb05814.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

Review 2.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

3.  Hydration of sickle cells using the sodium ionophore Monensin. A model for therapy.

Authors:  M R Clark; N Mohandas; S B Shohet
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

4.  Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.

Authors:  D R Powars; W A Schroeder; J N Weiss; L S Chan; S P Azen
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

5.  Evaluation of clinical severity in sickle cell disease.

Authors:  B F Cameron; E Christian; J S Lobel; M H Gaston
Journal:  J Natl Med Assoc       Date:  1983-05       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.